![Elizabeth Bhatt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Elizabeth Bhatt
Präsident bei
SEPTERNA, INC.
Vermögen: 6 Mio $ am 31.07.2026
Profil
Elizabeth P.
Bhatt is currently President & Chief Operating Officer at Septerna, Inc., a position starting in 2025.
Former positions include Independent Director at Locust Walk Acquisition Corp., Independent Director at eFFECTOR Therapeutics, Inc. from 2020 to 2024, Vice President-Corporate Development at Gilead Sciences, Inc. from 2016 to 2017, Chief Operating & Business Officer at Achaogen, Inc. from 2018 to 2019, and Chief Business & Strategy Officer at Applied Molecular Transport, Inc. from 2019 to 2022.
Education includes undergraduate studies at Pomona College and an MBA from Kellogg School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SEPTERNA, INC. 0,39 % | 11.08.2026 | 174.209 ( 0,39 % ) | 6 Mio $ | 31.07.2026 |
Aktive Positionen von Elizabeth Bhatt
| Unternehmen | Position | Beginn |
|---|---|---|
| SEPTERNA, INC. | Präsident | 01.08.2025 |
Ehemalige bekannte Positionen von Elizabeth Bhatt
| Unternehmen | Position | Ende |
|---|---|---|
| EFFECTOR THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 21.06.2024 |
| APPLIED MOLECULAR TRANSPORT INC. | Corporate Officer/Principal | 31.05.2022 |
| ACHAOGEN | Geschäftsführer | 30.06.2019 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01.09.2017 |
| EFFECTOR THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Elizabeth Bhatt
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
76
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections | Health Technology |
Pomona College
 Pomona College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Applied Molecular Transport, Inc.
 Applied Molecular Transport, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company that designs and develops novel oral biologic products | Commercial Services |
Locust Walk Acquisition Corp.
 Locust Walk Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
eFFECTOR Therapeutics, Inc.
 eFFECTOR Therapeutics, Inc. BiotechnologyHealth Technology Operates as a oncology company which develops therapies for cancer | Health Technology |
Septerna, Inc.
 Septerna, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that discovers and develops G protein-coupled receptor oral small molecule products for the treatment of hypoparathyroidism | Health Technology |
